| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc8133ee6f7033a7aebf397dcb23ad34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52d5f6baed4c6cc0e33e00b4e827cee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bcb91218f2df7c80f942b0196c1b56d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489bd089633ef949d7a53a68e7adfbb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_313e5618016be17c7b49b938c2410674 |
| publicationDate |
2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2187926-B1 |
| titleOfInvention |
Prevention of diabetes by administration of gliadin |
| abstract |
The invention herein is related to intranasal or other mucosal administration of gliadin, or parts thereof, to prevent the development of type 1 diabetes. This environmental antigen, which may have etiological role in the development of diabetes in genetically predisposed individuals, has been successfully applied in the prevention of disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017058074-A1 |
| priorityDate |
2007-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |